TOPIC PATHWAY

Capsules and powders

Reference formulations and procedures for capsules and powders, with separate records for calculations and testing.

This pathway organises your reading. Formulation, scope, sources and decisions remain in each full document.

Procedures and tools

SOP-007Calculations and weighing
SOP-011Powders and hard capsules
SOP-013Sampling, QC and release
F-002Master formulation record
F-003Blank batch record
PUB-017Analytical testing and actual delivered dose

Related monographs

23 records in the collection

CGR-BE-001
Diluent A FTM — lactose
Reference monograph · Local adoption
CGR-BE-002
Diluent B FTM — mannitol
Reference monograph · Local adoption
CGR-BE-014
Spironolactone capsules 25 mg FTM
Reference monograph · Local adoption
CGR-BE-016
Paracetamol capsules 250–500 mg FTM
Reference monograph · Local adoption
CGR-BE-019
Riboflavin capsules 400 mg FTM
Reference monograph · Local adoption
CGR-FR-009
Carmine capsules 200–500 mg Ph. Fr.
Reference monograph · Local adoption
CGR-FR-010
Nadolol capsules 1–50 mg Ph. Fr.
Reference monograph · Local adoption
CGR-FR-013
Therapeutic placebo capsules Ph. Fr.
Reference monograph · Local adoption
CGR-FR-014
Spironolactone capsules 0.5–25 mg Ph. Fr.
Reference monograph · Local adoption
CGR-FR-015
Sodium chloride capsules 50 mg–1 g Ph. Fr.
Reference monograph · Local adoption
CGR-FR-016
Amiodarone hydrochloride capsules 5–200 mg Ph. Fr.
Reference monograph · Local adoption
CGR-FR-017
Sodium bicarbonate capsules Ph. Fr.
Reference monograph · Local adoption
CGR-BE-031
Acetazolamide Capsules 250 mg
Reference monograph · Local adoption
CGR-BE-032
Hydrocortisone Capsules 10 or 20 mg
Reference monograph · Local adoption
CGR-BE-033
Cetirizine Dihydrochloride Capsules 10 mg
Reference monograph · Local adoption
CGR-BE-034
Diosmin Capsules 500 mg
Reference monograph · Local adoption
CGR-BE-035
Loperamide Hydrochloride Capsules 2 mg
Reference monograph · Local adoption
CGR-FR-029
Amoxicillin 125 / 250 / 500 mg capsules from bulk API
Reference monograph · Local adoption
CGR-FR-031
Clarithromycin 250 / 500 mg capsules
Reference monograph · Local adoption
CGR-FR-033
Sertraline 25 / 50 mg capsules
Reference monograph · Local adoption
CGR-FR-034
Quetiapine 50 / 100 / 150 mg immediate-release capsules
Reference monograph · Local adoption
CGR-ES-049
Capsule diluent 1 EX013
Reference monograph · Local adoption
CGR-ES-050
Capsule diluent 2 EX014
Reference monograph · Local adoption